GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (XSWX:MOVE) » Definitions » EV-to-FCF

Medacta Group (XSWX:MOVE) EV-to-FCF : -364.03 (As of May. 11, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Medacta Group EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medacta Group's Enterprise Value is CHF2,496.5 Mil. Medacta Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-6.9 Mil. Therefore, Medacta Group's EV-to-FCF for today is -364.03.

The historical rank and industry rank for Medacta Group's EV-to-FCF or its related term are showing as below:

XSWX:MOVE' s EV-to-FCF Range Over the Past 10 Years
Min: -4774.75   Med: 91.81   Max: 1218.41
Current: -354.72

During the past 9 years, the highest EV-to-FCF of Medacta Group was 1218.41. The lowest was -4774.75. And the median was 91.81.

XSWX:MOVE's EV-to-FCF is ranked worse than
100% of 363 companies
in the Medical Devices & Instruments industry
Industry Median: 27.99 vs XSWX:MOVE: -354.72

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-11), Medacta Group's stock price is CHF116.40. Medacta Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF2.282. Therefore, Medacta Group's PE Ratio for today is 51.01.


Medacta Group EV-to-FCF Historical Data

The historical data trend for Medacta Group's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medacta Group EV-to-FCF Chart

Medacta Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only -162.63 77.56 -5,095.52 987.86 -399.67

Medacta Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5,095.52 - 987.86 - -399.67

Competitive Comparison of Medacta Group's EV-to-FCF

For the Medical Devices subindustry, Medacta Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medacta Group's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Medacta Group's EV-to-FCF falls into.



Medacta Group EV-to-FCF Calculation

Medacta Group's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2496.514/-6.858
=-364.03

Medacta Group's current Enterprise Value is CHF2,496.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medacta Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-6.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medacta Group  (XSWX:MOVE) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Medacta Group's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=116.40/2.282
=51.01

Medacta Group's share price for today is CHF116.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medacta Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF2.282.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Medacta Group EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Medacta Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Medacta Group (XSWX:MOVE) Business Description

Traded in Other Exchanges
Address
Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Medacta Group SA is a Switzerland based company involved in developing, manufacturing and distributing orthopaedic and neurosurgical medical devices worldwide. The company offers solutions for Hip, Knee, Shoulder and Spine.